Market cap
$147 Mln
Revenue (TTM)
$45 Mln
P/E Ratio
--
P/B Ratio
8.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.1 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-17.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0
-
Face value
--
-
Shares outstanding
45,933,000
10 Years Aggregate
CFO
$-10.25 Mln
EBITDA
$-7.14 Mln
Net Profit
$-24.88 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Repro Med Systems (KRMD)
| -44.8 | -21.3 | -22.7 | -24.5 | 7.4 | 0.1 | 23.5 |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Repro Med Systems (KRMD)
| 50.9 | 56.2 | -31.2 | 19.0 | -50.2 | -7.8 | 295.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Repro Med Systems (KRMD)
|
3.2 | 147.4 | 45.1 | -1.8 | -4.0 | -10.4 | -- | 8.4 |
| 61.5 | 8,484.6 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.1 | |
| 14.5 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 57.5 | 9,074.5 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 180.0 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.5 | 6,525.3 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24 | 5.0 | |
| 90.3 | 5,420.5 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 321.8 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 178.2 | 10,222.2 | 785.1 | 41.5 | 9.9 | 2 | 251.6 | 4.8 |
Shareholding Pattern
View DetailsAbout Repro Med Systems (KRMD)
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to... deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey. Read more
-
President, CEO & Director
Ms. Linda M. Tharby
-
President, CEO & Director
Ms. Linda M. Tharby
-
Headquarters
Mahwah, NJ
-
Website
FAQs for Repro Med Systems (KRMD)
What is the current share price of Repro Med Systems Inc (KRMD) Today?
The share price of Repro Med Systems Inc (KRMD) is $3.21 (NASDAQ) as of 28-Aug-2026 13:34 EDT. Repro Med Systems Inc (KRMD) has given a return of 7.42% in the last 3 years.
What is the current PB & PE ratio of Repro Med Systems Inc (KRMD)?
Since, TTM earnings of Repro Med Systems Inc (KRMD) is negative, P/E ratio is not available.
The P/B ratio of Repro Med Systems Inc (KRMD) is 8.36 times as on 21-Aug-2026, a 118 premium to its peers’ median range of 3.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-101.73 |
15.74 |
2024 |
-29.13 |
10.51 |
2023 |
-8.16 |
5.51 |
2022 |
-18.70 |
5.17 |
2021 |
-29.30 |
3.66 |
What is the 52 Week High and Low of Repro Med Systems Inc (KRMD)?
The 52-week high and low of Repro Med Systems Inc (KRMD) are Rs 6.61 and Rs 3.14 as of 29-Aug-2026.
What is the market cap of Repro Med Systems Inc (KRMD)?
Repro Med Systems Inc (KRMD) has a market capitalisation of $ 147 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Repro Med Systems Inc (KRMD)?
Before investing in Repro Med Systems Inc (KRMD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.